Freespira
Latest round
- Series D
Last raised
- Dec 2020
Total raised
- $20M
Investors
- 4
About Freespira
Freespira, Inc.Founded in 2013 in Kirkland, US, Freespira, Inc. specializes in treatment for panic disorder and PTSD through a unique breathing regulation program. The company has undergone strategic developments to enhance its offerings but has no known subsidiaries. The firm was co-founded by Beth Siegelman, with Dean Sawyer and Joseph Perekupka currently serving as key executives. In April 2024, Freespira, Inc. Freespira offers an innovative, medication-free treatment specifically designed to address symptoms associated with panic disorder and post-traumatic stress disorder (PTSD) through a breathing regulation program. The core service includes two daily 17-minute sessions utilizing a small breathing sensor and a tablet that provides real-time feedback, complemented by training and weekly check-ins with a coach. This method is founded on the understanding that breathing irregularities and hypersensitivity to carbon dioxide are often linked to panic and PTSD symptoms, thus aiming to teach patients how to self-regulate their breathing patterns. Freespira's primary clientele includes individuals aged 13 and older suffering from anxiety and stress, with a significant focus on veterans and those experiencing trauma-related symptoms. The treatment is currently available in multiple geographical markets across the United States and Canada. Freespira's revenue generation model primarily revolves around a direct-to-consumer approach, where clients access treatment through a structured program that includes coaching and technological support. The firm engages customers via an all-inclusive package that encompasses the breathing sensor, tablet, and ongoing coaching sessions, establishing a comprehensive service offering tailored to meet the needs of its users. The program is designed to deliver lasting results within a 28-day treatment window, focusing on patient outcomes and evidence-based results. In April 2024, Freespira, Inc.
Who invested in Freespira
4 investors across 3 rounds
See all investors in Freespira
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Freespira
Who invested in Freespira?
Freespira has 4 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Freespira raised?
Freespira has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Freespira last raise money?
Freespira's most recent round on record is a Series D, in Dec 2020.
What does Freespira do?
Freespira is a medical devices & equipment company.
Where is Freespira headquartered?
Freespira is headquartered in Kirkland, US.
Which VCs invest in companies like Freespira?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back medical devices & equipment companies at Freespira's stage. Their profiles are linked below.
VCs backing medical devices & equipment startups at Series D
Raising like Freespira? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.